Persistence and Adherence to PCSK9 Inhibitor Monoclonal Antibodies Versus Ezetimibe in Real-World Settings.
Muntner P, Ghazi L, Jones J, Dhalwani N, Poudel B, Wen Y, Chen L, Wang Z, Bittner V, Kalich B, Farkouh ME, Woodward M, Colantonio LD, Rosenson RS.
Muntner P, et al. Among authors: wen y.
Adv Ther. 2024 Jun;41(6):2399-2413. doi: 10.1007/s12325-024-02868-z. Epub 2024 Apr 30.
Adv Ther. 2024.
PMID: 38691317
Free PMC article.